Shalini Parekh supports clients with market access and reimbursement strategy related to the Centers for Medicare & Medicaid Services (CMS)'s alternative payment models and other federal programs.
She leverages her experience in Medicare data analytics, payment policy, and quantitative program evaluation.
Prior to joining Avalere, Shalini was a vice president at The Lewin Group, where she managed the quantitative evaluation of the CMS’s Oncology Care Model (OCM), an alternative payment model focused on episodes of care initiated by chemotherapy. Shalini led a team of economists and data analysts in assessing the impact of OCM practice transformation requirements and financial incentives on claims-based payment, utilization, and quality of care outcome measures. Before that, Shalini spent several years at Acumen, LLC, directing CMS contracts focused on the Medicare Part D prescription drug program. This work included building analytic and reporting tools to measure and monitor Part D drug plan performance across dimensions such as patient safety and benefit administration, in addition to supporting Part D payment reconciliation and implementation of the coverage gap discount program.
Shalini has an MA in economics from the University of California, San Diego, and a BS in economics/mathematics from the University of Southern California.